
Minder®: Bridging monitoring gaps in epilepsy patient care
Minder revolutionises the patient journey by extending the monitoring window and enabling continuous EEG capture. This innovative system potentially improves the quality of life for patients, by supporting drug therapy monitoring and pre-surgical planning.
Years-long continuous monitoring
Minder can record continuously for up to 3 years (and has been used in patients for over 5 years), which is significantly longer than traditional EEG methods that typically last from minutes to a few days.
High-quality signal
The system provides signal quality equivalent to standard 10-20 scalp EEG but with lower noise levels, ensuring reliable data capture.
Remote monitoring
Minder includes secure cloud-based access for healthcare professionals, enabling remote care and regular clinical assessment without requiring patients to visit medical facilities.
First FDA-authorised* iCEM system
Providing unprecedented long-term epilepsy insights through continuous sub-scalp monitoring that captures what traditional EEGs miss.
The Minder System

Minder Implant
The Minder Implant is a device placed under the scalp with several sensors that can record brain activity (EEG signals) continuously for very long periods - months or even years. These sensors connect to a small transmitter that's also implanted, which wirelessly sends the brain activity data through the skin to the Minder Wearable.

Minder Wearable
The Minder Wearable receives and stores EEG recordings wirelessly transmitted from the Minder Implant, then transfers this data to the Minder App, running on a smartphone. It is powered by a rechargeable battery.

Minder App
The Minder App collects and transmits EEG data from the Minder Wearable via Bluetooth and uploads it to Minder Cloud for secure storage and processing. It can also record entries for a patient's seizure diary.

Minder Cloud
Minder Cloud offers a secure online portal that allows healthcare professionals to access and download patient data for viewing.
Minder is the first FDA-authorised* implantable continuous EEG monitoring device
The Minder System is an electroencephalographic (EEG) recording and transmitting device implanted under the scalp. It is a prescription device indicated to acquire, transmit, and store EEGs continuously from patients between 18-75 years of age with drug-resistant epilepsy who are intolerant or not indicated for more conservative monitoring tools. The Minder System is intended to aid in a physician's remote assessment and monitoring of the indicated patient's condition. Remote patient assessment and monitoring for this use is defined as the patient's EEG data is available for review by a healthcare provider located at a different location from the patient and where the data is being collected.
The medical use of the data acquired by the Minder System is to be performed under the direction and interpretation of a licensed medical professional. The Minder System does not provide any diagnostic conclusions about the patient's condition.

Proven safety and effectiveness of Minder
The UMPIRE clinical study confirmed that the Minder System is both safe and effective for patients. With a high acceptance rate, it provides valuable insights into brain activity.
Signal quality
Signal quality shown to be equivalent to 10-20 scalp EEG.
Effective insights
~90% of physicians were able to use the data from Minder to provide clinically meaningful insights to their patients.
Usability validation
90% of patients found the device easy to use.
Reliable platform
Minder builds upon Cochlear's proven technology, leveraging their established reliability, performance, and clinical experience with hundreds of thousands of implanted patients worldwide.
Important information
- The Minder System does not provide diagnostic conclusions
- Use of the Minder System must be under the direction of a licensed medical professional